Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression profile at single cell level of BM MNCs and NK/T cells from CCUS patients and healthy donors

ABSTRACT: To evaluate whether a dysfunctional immune phenotype could contribute to the maintenance of CCUS HSPCs, we performed single-cell RNA sequencing analyses of heathy donor and CCUS bone marrow (BM) mononuclear cells and dissected the intercellular crosstalk between each BM population

ORGANISM(S): Homo sapiens

PROVIDER: GSE276360 | GEO | 2025/03/05

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Gene expression profile at single cell level of BM MNCs from CCUS patients and healthy donors

Project description:To evaluate whether wild-type cells from CCUS patients are transcriptionally dysfunctional, we performed long-read single-cell RNA sequencing analyses of heathy donor and CCUS bone marrow (BM) mononuclear cells.

2025-03-05 | GSE276974 | GEO

Transcriptomic analysis of BM-MSCs identified EGR1 as a transcription factor to fully exploit their therapeutic potential

Project description:Bone marrow-mesenchymal stromal cells (BM-MSCs) are key components of the BM niche, where they regulate hemato-poietic stem progenitor cells (HSPCs) homeostasis by direct contact and secreting soluble factors. BM-MSCs also protect the BM niche from excessive inflammation by releasing anti-inflammatory factors and modulating immune cell activity. Thanks to these proper-ties, BM-MSCs were successfully employed in pre-clinical HSPC transplantation models, increasing the rate of HSPC engraftment, accelerating the hematological reconstitution, and reducing the risk of graft failure. However, their clinical use requires extensive in vitro expansion, altering their biological and functional properties. In this work, we analyzed the transcriptomic profile of human BM-MSCs sorted as CD45neg, CD105+, CD73+, and CD90+ cells from the BM aspirates of heathy-donors and corresponding ex-vivo expanded BM-MSCs. We found the expression of immune and inflammatory genes downregulated upon cell culture and selected the transcription factor EGR1 to restore the MSC properties. We overexpressed EGR1 in BM-MSCs and performed in vitro tests to study the functional properties of EGR1-overexpressing BM-MSCs. We concluded that EGR1 increased the MSC response to inflam-matory stimuli and immune cell control and potentiated the MSC hematopoietic supportive activity in co-culture assay, suggesting that the EGR1-based reprogramming may improve the BM-MSC clinical use.

2025-01-01 | GSE253276 | GEO

Project description:bm Raw sequence reads

| PRJNA886391 | ENA

Gene expression profile at single cell level of BM MNCs and NK/T cells from CCUS patients and healthy donors

Project description:Gene expression profile at single cell level of BM MNCs and NK/T cells from CCUS patients and healthy donors

| PRJNA1156777 | ENA

Gene expression profile at single cell level of BM MNCs from CCUS patients and healthy donors

Project description:Gene expression profile at single cell level of BM MNCs from CCUS patients and healthy donors

| PRJNA1159863 | ENA

The impact of remote solid tumors on bone marrow ecosystem at single-cell resolution

Project description:The bone marrow (BM) environment (BME) is inhabited by hematopoietic stem and progenitor cells (HSPCs) and niche cells, which are sources of bone homeostasis, hematopoiesis and immune response. The BM senses many pathological insults, including solid cancers. However, a comprehensive understanding of BM ecosystem response to solid cancer is lacking. Herein, by single-cell RNA sequencing, we characterized the BM landscape in tumor-bearing models prior to metastasis. We found that remote tumors induce dramatic systemic BM niche remodeling that drives HSPC reprogramming and dysfunctional hematopoiesis, which is distinct from innate immune responses.

2023-05-03 | GSE188648 | GEO

ChIP-on-chip from multiple donors of BM-MSCs with H3K4me3 and H3K27me3

Project description:Bone marrow-derived multipotent stromal cells (BM-MSCs) exhibit therapuetically valuable properties, including the capacity to differentiate into skeletal tissues and modulate immune system activity. These properties depend on proper regulation of dynamic gene expression in response to environmental and developmental stimuli. This study used chromatin immunoprecipitation (ChIP) coupled with human promoter tiling microarray analysis (ChIP-on-chip) to profile histones H3K4me3 and H3K27me3 at promoters genome-wide. The goal of the study was to identify gene promoters marked by H3K27me3 and H3K4me3 in BM-MSCs.

2015-02-09 | GSE64172 | GEO

Spatial Transciptomics of human trephine BM samples from AML patients and healthy donors

Project description:We have identified a novel cell subtype within acute myeloid leukemia progression, termed regeneration enrcihed cells (RECs) and aimed to assay its presence and location within the human BM tissue as compared to healthy

2024-04-05 | GSE255217 | GEO

The regulatory mechanisms of SIS3 on bone marrow-derived NK (BM-NK) cells under TGF-β stimulation using RNA sequencing

Project description:To explore the underlying mechanisms of SIS3 attenuating TGF-β-induced immunosuppression on NK cells, RNA-sequencing was performed on primary BM-NK cells under TGF-β stimulation with or without SIS3 pre-treatment.

2025-03-16 | GSE198766 | GEO

Identification of differentially expressed miRNAs in BM+ vs. BM- lung cancer samples

Project description:Brain metastasis (BM) can affect up to 25% of non-small cell lung cancer (NSCLC) patients during their lifetime. Efforts to characterize patients that will develop BM have been fairly disappointing. Small non-coding microRNAs (miRNAs) regulate the expression of target mRNAs by repressing their translation or regulating their sequence-specific degradation. miRNAs play a role in regulating a variety of targets and, consequently, multiple pathways, which makes them a powerful tool to be exploited for early detection of disease, risk assessment, and prognosis. In this study, we investigated miRNAs that may serve as biomarkers to differentiate between NSCLC patients with and without BM. miRNA microarray profiling was performed on samples from clinically matched NSCLC from patients with BM (BM+) and without BM (BM-). miR-328 and miR-330-3p were able to correctly classify BM+ vs. BM- patients. Gene expression analysis comparing NSCLC parental and stably transfected miR-328 cells identified several significantly differentially-expressed genes, whose expression may be directly or indirectly regulated by miR-328.

2011-02-16 | GSE23019 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data